Scientists at UC Santa Barbara in collaboration with research partners at the University of Utah are developing a broad spectrum vaccine that will protect against hundreds of strains of Salmonella. The research, published in the November 2008 issue of Infection and Immunity, works by disarming a genetic switch. As an additional benefit the vaccine does NOT induce inhibitory immune cells known to cause immune declines in cancer patients. The vaccine is still in re-clinical testing.
adaptive immunity Alzheimer's Disease antibiotics antibodies apoptosis autism bacteria Breast cancer C. elegans cancer chromatin circadian clocks CRISPR cryo-electron microscopy DNA Drosophila Epigenetics eukaryotes evolution gene expression Genomics HIV HIV AIDS human genome immunity metabolism microRNA miRNA mitochondria mRNA neural circuits neurodegeneration neurons obesity optogenetics Parkinson's Disease pathogenesis proteomics ribosomes RNA Saccharomyces cerevisiae stem cells synapses transcription vaccines